BioSpace News Archive

Multi-center team led by scientists at Cincinnati Children’s reports finding a ‘good’ form of inflammation that allows mice to avoid obesity

Leading vendors of analytics are paving the way for investments and adoption of analytics technology by accelerating the modernization process and decision-making to become more data-driven, according to Nucleus Research’s Analytics Technology Value Matrix 2021.

Edwards Lifesciences announced the results of a real-world study comparing outcomes for patients with bicuspid aortic stenosis who were treated with SAPIEN 3 and SAPIEN 3 Ultra Transcatheter Aortic Valve Replacement and at low risk of death from surgery.

Oculogica , a leader in concussion diagnosis and categorization, with the only FDA-cleared technology that aids in the diagnosis of concussion without a pre-injury baseline test requirement, announced today it has received a U.S. Army Medical Research and Development Command (USAMRDC) grant for $2 million to develop a wearable version of its technology.

9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, today announced that the Companys CEO, John Temperato will present a corporate update at Oppenheimers Rare & Orphan Disease Summit and invites investors to participate via webcast and in one-on-one meetings.

The Company brings the health benefits of its flagship product VINIA(R) to the United States Market.

Kalexsyn Inc. (Kalexsyn), a world-class CRO and CDMO providing chemistry services to the biotechnology and pharmaceutical industry, announced today that its Board of Directors appointed Brian Eklov to succeed Robert Gadwood, who is retiring, as Chief Executive Officer and Board member.

Universal PropTech Inc. (TSXV: UPI) (OTCQB: UPIPF) (FSE: 8LH) (“UPI” or the “Company”) is pleased to announce that ISBRG Corp., in which UPI owns a minority interest (see press release dated February 18, 2021), announced progress related to the ongoing development of its COVID-19 diagnostic device - SpotLight-19©.

Companies Implement Ineffective Screenings to Give Employees and Customers Misleading Reassurance [18-May-2021] WATERTOWN, Mass. , May 18, 2021 /PRNewswire/ -- A new study 1 published in the Journal of Occupational and Environmental Medicine (JOEM) shows senior management overriding the advice of their medical directors regarding screening employees with non-co

Universal PropTech Inc. (TSXV: UPI) (OTCQB: UPIPF) (FSE: 8LH) (“UPI” or the “Company”) today announced that Christopher Hazelton, Chief Executive Officer of UPI, executed an open market stock purchase for 440,000 common shares of the Company through the facilities of the TSX Venture Exchange (“TSXV”) on May 13, 2021, valued at approximately $115,000.